Management of tricuspid atresia with orally administered prostaglandin E2.
D000015:Abnormalities, Multiple; D000284:Administration, Oral; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy*; D006330:Heart Defects, Congenital; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011458:Prostaglandins E / Q000008:administration & dosage*; D014261:Tricuspid Valve / Q000002:abnormalities*
D011458:Prostaglandins E